Skip to main content
Equibles

VISTN · VISTIN PHARMA ASA

Use VISTN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research VISTN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
18.2500 NOK 15-min delayed · Oct 6, 12:09 UTC
Rebalance outlook locked
Market Cap
811.51M NOK
Shares
44.34M

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Investor day
Close18.2500 NOK Open18.6000 NOK Day18.2500–18.6000 NOK 52W close18.1000–23.2000 NOK Avg vol 30d13K Last earningsDec 2, 2026 DataJan 2020–Oct 2026

Technicals

trend & momentum for long-term holders illustrative — not investment advice
Price context
position in its 52-week range
Range low 18.1000 NOK Now 18.2500 NOK · 3% Range high 23.2000 NOK
vs 200-day avg -12% vs 50-day avg -5%

Illustrative technical + ownership context — a signal mix, not investment advice.

Performance

5D 20D 120D MTD YTD
XOSL:VISTN -1.4% -4.0% -19.3% -1.4% -12.3%

Exchange listing

Market
XOSL
Ticker
VISTN
ISIN
NO0010734122
Security
—
Trading currency
NOK

Company

Website
https://www.vistin.com/
Investor relations
https://www.vistin.com/investors

Other listings of this company

No other verified listings are available.

Latest trade

15-minute delayed

18.2500 NOK

8 shares at 2026-10-06 12:09:23 UTC (14:09:23 local)

Session
2026-10-06
Open
18.5000
High
18.5000
Low
18.1000
Volume
1,090

Recent dividends

Ex-dividend dateAmount per share
2026-05-221.0000 NOK
2025-06-041.2500 NOK
2024-11-060.5000 NOK
2024-06-050.5000 NOK
2024-01-230.7500 NOK
2021-05-210.5000 NOK
2020-05-201.0000 NOK

Upcoming investor events

DateEventType
2026-12-02 00:00 UTC Vistin Pharma ASA: Fourth quarter and preliminary 2025 financial results Results publication
2026-12-02 00:00 UTC Vistin Pharma ASA (VISTN): Key information relating to the proposed cash dividend Event

Earnings calls

  • Earnings call · Q4 2026 2026-12-02 Scheduled
    Vistin Pharma ASA: Fourth quarter and preliminary 2025 financial results
  • Earnings call · Q2 2026 2026-08-13 Audio Transcript
    Vistin Pharma ASA: Invitation to Q2 2026 conference call
  • Annual General Meeting · May 2026 2026-05-20
    Vistin Pharma ASA: Minutes from the annual general meeting 2026
  • Earnings call · Q4 2025 2026-05-02 Audio Transcript
    Vistin Pharma ASA (VISTN): Invitation to Q4 2025 conference call
  • Annual General Meeting · April 2026 2026-04-28
    Vistin Pharma ASA: Notice of Annual General Meeting 20 May 2026
  • Earnings call · Q1 2026 2026-04-17 Audio
    Vistin Pharma ASA: Invitation to Q1 2026 conference call